First-in-Human Pilot Study of Epicardial Circular RNA-HM2002 Injection in CABG for Ischemic Heart Failure

NCT06621576 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

3

Enrollment

OTHER

Sponsor class

Conditions

Ischaemic Heart Disease
Heart Failure

Interventions

DRUG: HM2002 injection

Sponsor

Ruijin Hospital

Collaborators

Shanghai CirCode Biomed Co.,Ltd
Shanghai Bestudy Medical Technology Co., Ltd